Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157
Tel: +81 (0)80-1164-4754
Request a Demo
What our customers are saying
When I think of the future, I think of EvaluatePharma
Global pharmaceutical company
Evaluate Bolsters Custom Services Capabilities to Meet Growing Demand for Expert Analytical and Data Services
LONDON, BOSTON, TOKYO (February 24, 2016) — Life science market intelligence firm Evaluate Ltd has strengthened its resources to support the continued growth of its project-based analytical and data services covering the pharma, biotech and medtech sectors. Paul Verdin joined Evaluate in 2015 to head up Custom Services and its dedicated analyst and technical team. Paul was previously at Thomson Reuters, where he played a key role in building the Life Sciences Professional Services organisation. He is supported by Jon Moser, Services Delivery Lead. Jon has deep industry and Evaluate data expertise, having developed and shaped the EvaluatePharma® subscription service since 2004.
“Evaluate’s Custom Services couple our deep industry expertise with our life science market intelligence, evaluation tools and forecasts. Frameworks and deliverables are designed in collaboration with our clients to maximise the value of our data, drive actionable insights, and help our clients solve their specific business problems”, said Paul Verdin.Some examples of the types of services offered include:
- Custom datasets based fully or partially on existing Evaluate content, aggregated, manipulated, and extended according to client needs
- Analytical solutions combining Evaluate content, targeted external research, industry expertise, and our structured and tailored methodologies
- Data management services to provide our clients with the right information, at the right time, and in the right format
To learn more about the Evaluate Custom Services please visit www.evaluate.com/customservices
About Evaluate Ltd.
Evaluate is the trusted source for life science market intelligence and analysis with exclusive consensus forecasts to 2020. Our subscription services include EvaluatePharma, EvaluateClinical Trials and EvaluateMedTech. Evaluate Custom Services provides project-based analytical and data services. Our award-winning editorial team, EP Vantage, leverages our strategic analysis to cut through the noise, giving you daily opinion and insights. The Evaluate service enable the life science community to make sound business decisions about value and opportunity.
For more information visit: www.evaluate.com. On Twitter: @evaluatepharma, @evaluatemedtech, @epclinicaltrial, @epvantage, @evaluateJP.
Back to Press Releases